We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Results of Lung Cancer CT Screening Show Impact on Death Rates

By MedImaging International staff writers
Posted on 01 Aug 2016
Print article
A new trial has found that lung cancer screening and early detection of lung cancer can prolong the lives of 70% of patients by one year or more.

In addition, the researchers also studied the long-term psychosocial outcomes of Computed Tomography (CT) lung cancer screening and found that screening did not result in unnecessary anxiety. The researchers did find that participants may face barriers such as fear and stigma that prevent their participation in a screening program.

The results of the trial were published in the July 2016 issue of the journal Thorax. The UK Lung cancer Screening trial (UKLS) was led by researchers at Cardiff University (Cardiff, UK), and included more than 4,000 women, and men, between 50 and 75 years old, who had a high risk of contracting lung cancer.

The results of the trial are intended to guide UK clinical and policy decisions for the implementation of potential future low-dose CT lung cancer screening for high-risk patients.

Dr. Kate Brain, Cardiff University, said, "With the UK's five-year survival rate for lung cancer being lower than many other countries with comparable healthcare systems, it is important that we do more to introduce early detection strategies that help to ensure treatment is delivered before patients present at an advanced stage of the disease. Sometimes, fear of medical procedures and the results they might bring can prevent people from seeking life-saving tests. However, what our trial shows is that CT lung cancer screening actually has no long-term negative psychosocial impact on patients, making it an excellent tool for catching lung cancer earlier when there is a better chance of survival."

Related Links:
Cardiff University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Portable X-Ray Unit
AJEX240H
New
Portable Radiology System
DRAGON ELITE & CLASSIC
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.